Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma

Pharmacogenetics and Genomics

Saved in:

書目詳細資料
Main Authors:	Lee, S.-C., Soo, R., Guo, J.-Y., Goh, B.-C., Lim, S.-G., Putti, T., Soong, R., Hsieh, W.-S., Tao, Q.
其他作者:	PHARMACOLOGY
格式:	Article
出版:	2012
主題:	EGFR EGFR mutations EGFR tyrosine kinase inhibitors Hepatocellular carcinoma Nasopharyngeal carcinoma
在線閱讀:	http://scholarbank.nus.edu.sg/handle/10635/33163
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
由: Lim, Chwee Ming, et al.
出版: (2022)

Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach
由: Salto-Tellez, M., et al.
出版: (2014)

EXPLORING RECEPTOR TYROSINE KINASES IN THE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
由: BHAVE SAYALI SHRIVARDHAN
出版: (2023)

Endofin is a novel component in EGR/EGFR oncogenic signaling
由: TOY WEIYI
出版: (2011)

Reversion of tumor hepatocytes to normal hepatocytes during liver tumor regression in an oncogene-expressing transgenic zebrafish model
由: Li, Y., et al.
出版: (2021)

Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: A multicentre immunohistochemical study in the Asia-Pacific region
由: Putti, T.C., et al.
出版: (2012)

Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement
由: Kim, H.R., et al.
出版: (2014)

EGF-induced tyrosine phosphorylation of Endofin is dependent on PI3K activity and proper localization to endosomes
由: Toy, W., et al.
出版: (2014)

The positive impact of cytological specimens for EGFR mutation testing in non-small cell lung cancer: A single South East Asian laboratory's analysis of 670 cases
由: Pang, B., et al.
出版: (2014)

Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors
由: Chin, T.-M., et al.
出版: (2021)

Transethosome-based topical administration systems with enhanced penetration and dual actions for treating EGFR-overexpressed cutaneous squamous cell carcinoma
由: Wang, Wenyan, et al.
出版: (2024)

Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses
由: Ninnutt Moonrin, et al.
出版: (2015)

Application of antibody-conjugated gold nanoparticles for optical molecular imaging of epithelial carcinoma cells
由: Kah, J.C.Y., et al.
出版: (2014)

CLINICAL AND FUNCTIONAL SIGNIFICANCE OF CD151 IN WILDTYPE EGRF NSCLC
由: WONG HUEE PING AMANDA
出版: (2020)

Potential therapeutic significance of HER-family in esophageal squamous cell carcinoma
由: Kono, K., et al.
出版: (2014)

Rhabdoid large cell carcinoma of lung, with illustrative immunohistochemical and molecular findings
由: Dettmer, M., et al.
出版: (2016)

mAb806 binding to epidermal growth factor receptor: a computational study
由: Ng, Yao Zong, et al.
出版: (2016)

Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease
由: Bhave, Sayali, et al.
出版: (2022)

ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
由: Jasinghe, V.J., et al.
出版: (2011)

Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish
由: Li, Z., et al.
出版: (2014)

Molecular contrast of EGFR expression using gold nanoparticles as a reflectance-based imaging probe
由: Kah, J.C.Y., et al.
出版: (2014)

Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian Lung adenocarcinomas
由: Toh, C.-K., et al.
出版: (2014)

The function of TOM1-L1 in bridging EGFR signaling and endocytosis
由: LIU NINGSHENG
出版: (2010)

Simulation of the regulation of EGFR endocytosis and EGFR-ERK signaling by endophilin-mediated RhoA-EGFR crosstalk
由: Ung, C.Y., et al.
出版: (2014)

OVEREXPRESSION OF TYRO3 AND ITS IMPLICATION ON HEPATOCELLULAR CARCINOMA (HCC) PROGRESSION
由: DUAN YAN
出版: (2011)

Agents for Hepatocellular Carcinoma: Synthesis and Mode of Action
由: CHEN XIAO
出版: (2014)

Discordance of epidermal growth factor receptor mutation between primary lung tumor and paired distant metastases in non-small cell lung cancer: A systematic review and meta-analysis
由: Lee, Chia Ching, et al.
出版: (2022)

EGFR S1166 phosphorylation induced by a combination of EGF and gefitinib has a potentially negative impact on lung cancer cell growth
由: Assiddiq, B.F., et al.
出版: (2014)

RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status
由: Omar, M.F.M., et al.
出版: (2014)

Tyrosine phosphorylation of transcriptional coactivator WW-domain binding protein 2 regulates estrogen receptor α function in breast cancer via the Wnt pathway
由: Lim, S.K., et al.
出版: (2014)

Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling
由: Wong, E.S.M., et al.
出版: (2014)

Investigations on Rab31's Role in EGFR Trafficking and Neural Progenitor Cell Differentiation Towards Astroglia
由: CHRISTELLE CHUA EN LIN
出版: (2014)

Nasopharyngeal carcinoma
由: Chong, V.F.H., et al.
出版: (2011)

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
由: Lacouture, M.E., et al.
出版: (2014)

Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
由: Yeo, W.-L., et al.
出版: (2011)

Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors
由: Li, Y., et al.
出版: (2014)

Lrg1 promotes metastatic dissemination of melanoma through regulating egfr/stat3 signalling
由: Kwan, Yuet Ping, et al.
出版: (2022)

Blocking aerobic glycolysis by targeting pyruvate dehydrogenase kinase in combination with egfr tki and ionizing radiation increases therapeutic effect in non-small cell lung cancer cells
由: Dyrstad, Sissel E., et al.
出版: (2022)

Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
由: Sudo, M., et al.
出版: (2014)

Quantification of epidermal growth factor receptor dynamics and interactions in living cells by fluorescent correlation and cross-correlation spectroscopy
由: MA XIAOXIAO
出版: (2014)